Evidence map›Paper›PMID 35496428›Full record

ArticleRSC advances2021

Synthesis and the growth mechanism of ultrafine silver nanowires by using 5-chloro-2-thienylmagnesium bromide as the additive.

Zhengyang Fan, Jie Chen, Huaming Mao, Jungang Yin, Wei Dai, Linlin He, Hongwei Yang

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhengyang FanState Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals, Kunming Institute of Precious Metals 650106 Kunming People's Republic of China nanolab@ipm.com.cn.
Jie ChenState Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals, Kunming Institute of Precious Metals 650106 Kunming People's Republic of China nanolab@ipm.com.cn.
Huaming MaoState Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals, Kunming Institute of Precious Metals 650106 Kunming People's Republic of China nanolab@ipm.com.cn.
Jungang YinState Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals, Kunming Institute of Precious Metals 650106 Kunming People's Republic of China nanolab@ipm.com.cn.
Wei DaiState Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals, Kunming Institute of Precious Metals 650106 Kunming People's Republic of China nanolab@ipm.com.cn.
Linlin HeState Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals, Kunming Institute of Precious Metals 650106 Kunming People's Republic of China nanolab@ipm.com.cn.
Hongwei YangState Key Laboratory of Advanced Technologies for Comprehensive Utilization of Platinum Metals, Kunming Institute of Precious Metals 650106 Kunming People's Republic of China nanolab@ipm.com.cn.ORCID https://orcid.org/0000-0002-6432-2119

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Synthesis of silver nanowires (Ag NWs) has been studied for decades. However, Ag NWs with diameters below 20 nm synthesised by simple and robust approaches are still rarely reported. In this work, Ag NWs with an average diameter of ∼15 nm and an aspect ratio of over 1000 have been prepared by using a Grignard reagent 5-chloro-2-thienylmagnesium bromide as an assistant additive. In particular, the presence of 5-chloro-2-thienylmagnesium bromide is proven to be beneficial for the

Identifiers

PMID35496428
PMCPMC9043635

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.